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Superoxide generated by NADPH Oxidase 5 (Nox5) is regulated by Ca2+ through the interaction of its selfcontained Ca2+ binding domain and dehydrogenase domain (DH). Recently, calmodulin (CaM) has been re
ported to enhance the Ca2+ sensitivity of Nox5 by binding to the CaM-binding domain sequence (CMBD), in
which the interaction between CaM and Nox5 is largely unclear. Here, we used the CMBD peptide and truncated
DH constructs, and separately studied their interaction with CaM by fluorescence, calorimetry, and dynamic light
scattering. Our results revealed that each half-domain of CaM binds one CMBD peptide with a binding constant
near 106 M-1 and a binding enthalpy change of − 3.81 kcal/mol, consistent with an extended 1:2 CaM:CMBD
structure. However, the recombinant truncated DH proteins exist as oligomers, possibly trimer and tetramer. The
oligomeric states are concentration and salt dependent. CaM binding appears to stabilize the DH dimer com
plexed with CaM. The thermodynamics of CaM binding to the DH is comparable to the peptide-based study
except that the near unity binding stoichiometry and a large conformational change were observed. Our result
suggests that the oligomeric states of Nox5, mediated by its DH domain and CaM, may be important for its
superoxide-generating activity.

1. Introduction
The NADPH Oxidase (Nox) enzymes are responsible for the pro
duction of reactive oxygen species (ROS) for cellular signaling, gene
regulation, and host immunological defense [1]. However, an imbalance
of cellular ROS production has been shown to be correlated with a va
riety of health complications such as cancer, as well as neurological,
renal, and cardiovascular disorders [2–7]. Superoxide is one type of ROS
produced primarily by Nox proteins. Several homologous enzymes have
been identified, including Nox1-5 and Dual Oxidase (Duox) [8]. These
Nox proteins are found in several tissues and have different activation
mechanisms. Among them, Nox2 (phagocytic Nox) is well documented
for its non-specific immunity by generating superoxide that kills
invading pathogens. However, more recent evidence indicates that all
non-phagocytic Nox enzymes play a role in cell defense in addition to
their roles in mediating redox signaling to maintain healthy cells.
All Nox proteins share similar sequence features, consisting of a
polypeptide homologous to gp91phox that contains a five-to-six trans
membrane heme domain and a flavoprotein or dehydrogenase (DH)

containing FAD and NADPH binding sites. An active complex formation
from accessory and/or regulatory proteins are required for Nox1-3 while
Nox4 is constitutively expressed as an activated form. Interestingly,
superoxide and hydrogen peroxide production by Nox5 and Duox are
Ca2+ dependent, through their additional self-contained N-terminal EFhand domain (EFD) [9]. Nox5 overexpression results in high ROS pro
duction and has been reported to be associated with disease develop
ment, including hairy cell leukemia [2], prostate cancer [3], diabetic
nephropathy [10], vascular diseases [5–7].
Though the Nox5’s superoxide-generating mechanism is not
completely understood, it is generally believed that Nox5’s EFD,
comprised of four EF-hand motifs (EFs), undergoes a Ca2+-dependent
conformational change to mediate the EFD-DH interaction. Such a
domain-domain interaction is essential to allow electron transfer from
NADPH to FAD, through the transmembrane hemes, and lastly ending
up on molecular oxygen. Previously, we demonstrated that the C-ter
minal end of Ca2+-bound EFD (Ca2+-EFD) binds specifically to the reg
ulatory EF-hand binding domain (REFBD) located in Nox5’s DH using
the REFBD peptide and truncated DH proteins [11]. The Ca2+-mediated
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domain-domain interaction is viewed as the main activation mechanism
for Nox5. However, other proteins including calmodulin (CaM), tyrosine
kinase, Hsp90, and caveolin have been reported to modulate the Nox5’s
superoxide-generating activity [12–15]. Among them, CaM is reported
to enhance Nox5’s Ca2+ sensitivity. The mechanism regarding the role of
CaM in assisting Nox5 activity is attractive because it is believed that the
Ca2+ level (0.1–1 μM) in the stimulated cells is not sufficient to activate
Nox5 due to its weak Ca2+ binding affinity [12]. However, we deter
mined that the Ca2+ binding constants (Ka) of EFD are in the range of
105–106 M-1 in physiological conditions, which is one order higher than
the previous reported values [12]. In comparison, the Ca2+ binding for
CaM is 104–105 M-1 [16]. Therefore, it is interesting that the Nox5 ac
tivity is regulated by two Ca2+-dependent protein components when
both share similarities in protein folds [11,17]. To enhance the Nox5’s
Ca2+ sensitivity, a synergy in increasing Ca2+ binding affinities for CaM
and Nox5′ EFD is expected for the activation at a lower Ca2+ concen
tration. In other words, the binding affinity of Ca2+ to Nox5’s EFD (or
CaM) increases in the presence of CaM (or Nox5’s EFD). This hypothesis
remains to be proven.
CaM and Nox5’s EFD consist of four EF-hand motifs (EFs) that bind to
four Ca2+ ions with their N-terminal lobe containing the 1st EF (EF1)
and EF2 and the C-terminal half-domain containing EF3 and EF4. The
half-domains are joined by a flexible linker region. CaM binds to a
conserved sequence called the CaM-binding domain (CMBD) in the
target enzymes. In Nox5, the CMBD sequence has been identified in the
DH region [18]. In this study, we aimed to explore the potential binding
mechanism of CaM to the DH of human Nox5β (hNox5) via isothermal
titration calorimetry, dynamic light scattering, and fluorescence. To
interrogate the role of CaM, we reported the binding thermodynamics of
CaM with the CMBD peptide and truncated DH proteins. The results
from this study are important to understand the role of CaM in Nox5
activity in future study.

and MBP-fused DH proteins including the residues 665–719 (DH665-719),
DH605-719, DH584-719, and DH528-719 were expressed and purified as
described elsewhere [11] with some modification. Briefly, the E. coli
cells containing the pMal-c2X plasmid with the DH gene inserted were
grown and expressed in Luria Broth containing 2 g/L of glucose and 1
mM ampicillin; they were induced with 0.3–0.5 mM Isopropyl
β-D-1-thiogalactopyranoside (IPTG) at OD600 = 0.4–0.6. The cells were
pelleted after 18 h of growth at room temperature. The pellets were then
sonicated and centrifuged at 15,000×g for 20 min. The resulting su
pernatant was loaded into a column containing 5 mL of dieth
ylaminoethyl (DEAE) cellulose (MilliporeSigma) equilibrated with 50
mM Tris, 100 μM EDTA, pH 7.5 (Buffer A). After washing with 10 bed
volumes of Buffer A, the desired DH protein was eluted with 2 bed
volumes of Buffer A plus 0.5 M NaCl. The eluted fraction was mixed with
an equal volume of Buffer A followed by loading it to an amylose column
(New England BioLabs, Ipswich, MA). After washing with 3 bed volumes
of Buffer CB (50 mM Tris, 0.2 M NaCl, 1 mM EDTA, pH 7.5.), a solution
of Buffer CB containing 10 mM maltose was used to elute the MBP-fused
DH. Lastly, the DH proteins were further purified with a
CaM-immobilized column [11]. Note that MBP-fused DHs were used for
characterization without the cleavage of MBP from DH due to the low
solubility of the DH domain proteins.
The recombinant 6xHis-tagged CaM was first purified with a Pro
Bond Ni-NTA Resin column (ThermoFisher) followed by a Phenyl
Sepharose column. The blue or cyan fluorescent protein (BFP or CFP)
fused CaM (CaM-BFP or CaM-CFP) and its N- and C-terminal half do
mains of CaM (residues 1–75, NCaM and residues 76–149, CCaM) were
prepared by cloning the corresponding CaM gene sequences into a
pRSET-BFP or pRSET-CFP vector (ThermoFisher) immediately before
the fluorescence proteins. The resulting plasmid was transformed to T7
or BL21(DE3) E. Coli cells (New England Biolabs) and the purification
was identical to CaM. All purified proteins were stored at - 80oC until use
or directly used after purification.

2. Experimental

2.4. Pulldown experiments

2.1. General

To identify the protein constructs that bind CaM or its individual
half-domains, three specific protein-immobilized columns were pre
pared using NHS-Activated Agarose Resin (ThermoFisher). To help
visualize the immobilization, BFP- or CFP-fused CaM proteins were used
intentionally. Briefly, 5 mg CaM-BFP, NCaM-CFP, or CCaM-BFP was
buffer-exchanged three times with Coupling Buffer (0.1 M sodium
phosphate, 0.15 M NaCl, pH 7.2) followed by a reaction with 2-mL of
activated agarose in three separate columns (1 cm × 2 cm) for 1 h at
room temperature. After washing with 4 mL of Coupling Buffer, the
remaining unreactive sites in resin were quenched with 2 mL 1 M Tris,
pH 7.5 followed by washing with 6 mL of Coupling Buffer. The columns
were stored in 50 mM Tris, 100 μM EDTA, pH 7.5 at 4 ◦ C.
The pulldown experiments were conducted by loading the DH pro
teins to the three columns equilibrated with Buffer B (50 mM Tris, 2 mM
Ca2+, pH 7.5). After washing the column with 10 mL of Buffer B, any
retained protein then was eluted with 5 mL buffer containing 50 mM
Tris, 5 mM EDTA, pH 7. All washing and eluted fractions from individual
columns were concentrated and adjusted to a final volume of 1-mL for
fair comparison on a 12–15% SDS-PAGE.

All chemicals were purchased from MilliporeSigma (St. Louis, MO)
and ThermoFisher Scientific (Waltham, MA) without further purifica
tion. The human Nox5β′ s CMBD peptide and the N-terminal Dansyllabeled fluorescent peptide with the sequence H2NRPDWSKVFQ
KVAAEKKGKVCOOH corresponding to 671–689 residues in a purity of
>95% were purchased from Abclonal (Cambridge, MA). The purity of
the proteins was estimated by SDS-PAGE electrophoresis and densi
tometry using UN-SCAN-IT software (Silk Scientific, Inc., Utah). All
proteins used in characterization have a purity >90%. All measurements
were performed at least three times using two to three different protein
batches, and the results are reproducible. When possible, the data pre
sented here are the mean values plus the standard deviation.
2.2. Concentration determination
The concentrations of the peptide and protein containing a single Trp
or Dansyl group were determined by using extinction coefficients (ε) of
5380 M-1cm-1 at 280 nm and 3400 M-1cm-1 at 338 nm for Trp and Dansyl
group, respectively. An ε276 value of 2900 M-1cm-1 was used to calculate
the CaM concentration [19]. The concentrations of the truncated DH
proteins were determined by a Bradford assay (ThermoFisher). Con
centrations were cross analyzed for validity when appropriate. For
example, the determined concentration of CaM by extinction coefficient
at 276 nm was checked against the determined concentration of
Dansy-labeled CaM using extinction coefficient for Dansyl group.

2.5. Spectroscopic measurements
Absorbance measurements were carried out using a UV-1800 Spec
trometer (Shimadzu, Kyoto, Japan). The fluorescence spectra were
recorded on the FluoroMax-3P or FluoroMax-4 (Horiba John Yvon, Inc.),
equipped with a temperature control unit and polarizers. To monitor Tyr
or Trp fluorescence, 2–5 μM of protein was excited at a wavelength of
280 or 295 nm. The excitation wavelength of 335 nm was used to
monitor fluorescence from the Dansyl group. The slit widths of 2 and 5
nm for excitation and emission were chosen for intensity measurements

2.3. Recombinant protein expression and purification
The recombinant 6xHis-tagged CaM, maltose binding protein (MBP),
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while the slit widths of 10 and 10 nm were used for the anisotropy
measurement. For the binding study of CaM and CMBD using Trp fluo
rescence, the emission spectra of CMBD alone and with different con
centrations of CaM were recorded. These spectra were then corrected
from the spectra from a separated titration, in which the same amounts
of CaM were titrated to the buffer at an identical setting, which are
attributed from CaM’s Tyrosine residues and water Raman. Unless
indicated elsewhere, the buffer was 50 mM Tris, pH7.5 with 2 mM Ca2+
or 1 mM EDTA. The equations and fittings from intensity changes and
anisotropy values were conducted as described previously [11].

7.5 was applied to a Wyatt disposable cuvette and left to equilibrate at
25 ◦ C for 2 min. The acquisition time was set to 5 s and the minimum
peak intensity was 1%. The intensity autocorrelation for low and high
cut off times were 0.5 and 100,000 μs. The resulting autocorrelation
functions were averaged 10 times to remove noise, which was fitted to
the decaying exponential functions to determine the diffusion coeffi
cient. The hydrodynamic radius (Rh) was calculated assuming the shape
of molecules are spherical in all cases.

2.6. Isothermal titration calorimetry (ITC)

3.1. Characterization of CaM with Nox5’s CMBD peptide

All ITC experiments were run on a VP-ITC (GE, Pittsburgh, PA) as
described elsewhere [20]. Typically, the ITC measurement was set for 5
or 10 μL injections dispensed over 10 or 20 s, respectively, with 120 s
spacing. The concentrations of the protein/peptide in the sample cell
ranged from 2 μM to 30 μM while the concentrations of the samples in
the syringe ranged from 100 μM to 500 μM. The resulting ITC data was
corrected for the heat of dilution from a control experiment, in which
titrant was injected to sample cell containing buffer only. The buffer
used was 50 mM Tris, 2 mM Ca2+, pH 7.5 When studying salt-dependent
binding, 0.15–0.25 M NaCl was included in the buffer. All data sets were
fitted with the “One Set of Sites” fitting function.

3.1.1. Binding determined by fluorescence
The Nox5’s CMBD contains a single Trp residue while it is absent in
CaM, making the system suitable for binding study using Trp fluores
cence. Previously, the binding for CaM and the CMBD peptide was
estimated with a Ka value of 4 x 107 M-1 and near unity stoichiometry
[18]. Those values were estimated by the titration curve with the in
flection point to determine the binding stoichiometry-a practice that
cannot determine the binding affinity precisely. Here we revisited the
system with the spectral correction and fitted the titration with
non-linear regression. Fig. 1A shows the corrected emission spectra of
the CMBD peptide and its complex with difference amounts of CaM in
the presence of Ca2+. The CMBD peptide exhibits a maxima emission
wavelength (λem) at 350 nm. Upon the addition of CaM, the fluorescence
has a blue shift to 330 nm. The large wavelength shift (~20 nm) in
dicates the Trp residue of CMBD is changed to a buried non-polar
environment, consistent with the KSV values of 6.225 M-1 for CMBD
and 0.726 M-1 for CaM/CMBD complex obtained from dynamic
quenching with potassium iodide (See supplementary figure; Fig. S1).
Our titration spectra roughly indicate that there are two distinct fluo
rescent species: the unbound CMBD peptide with λmax = 352 nm and
CaM-bound CMBD peptide with λmax = 330 nm. We observed the iso
sbestic point at 352 nm, not 364 nm in the previous report [18]. By
following the formation of the CaM/CMBD complex (i.e., monitoring at
330 nm), the titration requires nearly one equivalent of CaM to saturate
the binding, and the fitting results in a Ka value of 1.71 × 107 M-1 in a 2:1
(CMBD:CaM) binding (Insert in Fig. 1A).
Because the CMBD peptide is much smaller than CaM, we monitored
the complex formation by molecular tumbling using fluorescence
anisotropy. The emission wavelength at 352 nm was chosen since there
is no significant correction for quantum yields required for fitting and
there is low signal attributed from CaM. The Trp anisotropy value (r) of
the peptide alone was 0.0405. When a solution of 1 μM CMBD was

3. Results

2.7. Size-exclusion chromatography (SEC) or gel filtration
chromatography
The oligomeric states of the proteins were monitored by a highperformance liquid chromatography system (HPLC; Shimazu, Inc.,
Kyoto, Japan) with a Shodex PROTEIN KW802.5 column (Showa Denko
America, Inc, New York) controlled by LabSolutions software. The col
umn was equilibrated with a buffer containing 20 mM Tris, 0.2–0.5 M
NaCl, pH 7.5 with 2 mM Ca2+ or 1 mM EDTA. The settings for flow rate
and the wavelength for UV detector were 1.0 mL/min and 280 nm,
respectively. The protein samples were filtered through a 0.45 μm filter
before injecting into a 20-μL sample loop. When the fraction collector
was used, a calibrated delay of 330 μL was used for collecting fractions.
2.8. Dynamic light scattering (DLS)
The DLS experiments were performed on a DynaPro NanoStar (Wyatt
Technology, Santa Barbara, CA). Prior to measurement, all samples were
first filtered with a 0.45 μm filter followed by a 0.1 μm filter. Then, 20 μL
of the filtered sample at the concentration of 1 mg/mL in 50 mM Tris, pH

Fig. 1. The CMBD and CaM binding determined by fluorescence in the presence of Ca2+. (A) shows the corrected Trp fluorescence spectra of 2 μM CMBD upon the
addition of CaM. The Insert shows the fitting of a plot of the concentration versus the intensity at 330 nm. (B) shows the anisotropy measurement of 1 μM CMBD with
CaM with the emission at 352 nm. (C) shows the Dansyl fluorescence of 2 μM D-CMBD titrated with CaM. The curvature binding curve and slightly more than 1
equivalent of CaM for saturation indicate that the binding is not extremely strong, and CaM is capable of binding more than one ligand.
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Table 1
Binding affinities for CaM/CMBD. The binding measurements were conducted in the buffer containing 50 mM Tris, pH 7.5, 2 mM Ca2+ at room temperature for
fluorescence and at 25oC for ITC.
Binding by Fluorescence (titrant/analyte)

Binding constant
(M-1)

Stoichiometry (n[Peptide]/[Protein])

CaM/CMBD (intensity)
CaM/CMBD (anisotropy)
CaM/D-CMBD

(1.71 ± 0.60) × 107
(8.64 ± 2.25) × 106
(4.95 ± 1.03) × 106

2.10 ± 0.35
1.91 ± 0.24
2.11 ± 0.11

Binding by ITC (titrant/analyte)

Binding constant (M-1)

Stoichiometry (n[peptide]/Protein])

ΔHprotein (kcal/mol)

CMBD/CaM
CaM/CMBD
CMBD/NCaM
CMBD/CCaM

(8.78
(1.02
(2.42
(9.50

1.82 ±
1.79 ±
0.89 ±
1.04 ±

- 6.94
- 7.85
- 3.94
- 4.02

± 1.25)
± 0.21)
± 1.21)
± 0.62)

x 105
x 106
x 106
x 105

complexed with CaM, the anisotropy increases up to 0.136. The binding
curve is hyperbolic, and the saturation reaches at molar ratio near 1.2,
indicating the binding model cannot be 1:1 (Fig. 1B). In fact, the
anisotropy fitting yields the Ka and nCMBD/CaM values to be 8.64 × 106 M1
and 1.91. Our data seems to agree with the previous report about
binding affinity, but not stoichiometry [18]. However, the large stan
dard deviations from affinity and stoichiometry indicate the difficulty of
eliminating the fluorescence from CaM precisely (Table 1).
To avoid the fluorescence from CaM, we used an alternative means to
measure the binding. Firstly, we employed an N-terminal Dansyl-labeled
CMBD (D-CMBD). Fig. 1C shows the Dansyl fluorescence of the peptide
has a maximal emission at 550 nm, which shifts to 518 nm upon CaM
binding with ~ 8-fold intensity increases. The fitting yields the Ka and
the molar ratio of D-CMBD to CaM (i.e., nD-CMBD/CaM) value to 4.95 ×
106 M-1 and 2.11 (Table 1). The labeled peptide appears to bind CaM in
the absence of Ca2+. The emission spectra are very different to the ones
in the presence of Ca2+: the emission maxima and intensity changes are
much smaller. The binding affinity was estimated to be ~105 M-1, in
which the binding is primarily through electrostatic interactions, which
are diminished in a higher ionic strength (Fig. S2A&B). A similar finding
using CMBD’s Trp fluorescence was found in the absence of Ca2+
(Fig. S2C). Therefore, we concluded that such a Ca2+-independent
interaction is non-specific and not biologically importance because of

0.08
0.11
0.06
0.03

± 0.04
± 0.06
± 0.45
± 0.06

the high ionic strength (= ~0.25 M) in physiological condition.
3.1.2. Binding determined from isothermal titration calorimetry
We measured the heat evolved from the non-covalent interactions by
ITC. When the syringe containing 350 μM CMBD was titrated into a
solution containing 25 μM CaM in the presence of 50 mM Tris, 2 mM
Ca2+, pH 7.5, at 25oC, an exothermic reaction was observed, and the
inflection point of the titration curve revealed that molar ratio
([CBMD]/[CaM]) is near 2 (Fig. 2A). The data was fit well to the model
of “one set of sites”, yielding the Ka value of 8.78 × 105 M-1, the ΔH
value of − 3.81 kcal/mol, and the nCMBD/CaM value of 1.82. The results
indicate that there are two independent CMBD binding sites for CaM and
each has a binding affinity of 8.78 × 105 M-1 and heat enthalpy change
of − 3.81 kcal per mole CMBD (ΔHCMBD). Since we are interested in the
molar enthalpy change per CaM (ΔHCaM), it was calculated to be − 6.94
kcal/mol (i.e., ΔHCMBD × nCMBD/CaM). To verify this independent bind
ing, we employed a back-titration by injecting 250 μM CaM into 40 μM
CMBD (Fig. 2B); the obtained thermodynamic parameters were consis
tent to the previous titration, with the Ka value of 1.02 × 106 M-1, ΔHCaM
of − 7.85 kcal/mol, and nCaM/CMBD of 0.56 (i.e., nCMBD/CaM = 1.79).
Further, we replaced CaM with its half-domains (NCaM and CCaM) and
the binding affinities are comparable with near unity stoichiometry. The
enthalpy changes of the half-domains are close to ΔHCMBD, which was

Fig. 2. Binding of CaM and CMBD determined by isothermal titration calorimetry. (A) shows the representation of the titration by adding CMBD to 25 μM CaM in the
presence of 50 mM Tris, pH 7.5, 2 mM Ca2+ at 25oC. (B) shows the representation of the reverse titration by titrating CaM to 40 μM CMBD in an identical condition.
The n values from the fitting were 1.834 and 0.521 for (A) and (B), respectively, which are converted to the number of CMBD peptides per CaM tabulated in Table 1.
4
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of Ca2+, Dansyl fluorescence was found be in the fractions correspond
ing to CaM and the peptide. When a large excess of CaM was included,
the CMBD binding is driven to be complete as judged from the Dansyl
fluorescence that was only detected from the fractions near ~10 min
(Fig. 3C). Because of low separation resolution of the gel filtration, the
previously determined stoichiometry cannot be confirmed as D-CMBD is
relatively small (~2 kDa). Our results revealed that a stable
Ca2+-CaM/CMBD complex was formed in non-equilibrium system. The
Dansyl fluorescence was not detected in the CaM fraction in the absence
of Ca2+ (Fig. 3D).

determined from using intact CaM. In summary, we unambiguously
confirmed the binding between CaM and Nox5’s CMBD is in the range of
106 M-1, and CaM contains two independent CMBD binding sites. The
binding is specific and does not change significantly in the presence of
0.1 − 0.25 M NaCl.
3.1.3. The CaM/Nox5’s CMBD interaction determined by size-exclusion
chromatography
When the binding kinetics of CaM/CMBD complex were measured,
we failed to detect any meaningful kinetic traces using a stopped-flow
fluorescence device as used previously for the CaM/Orai system [21].
Therefore, our results implied that its association kinetics are much
faster than the dissociation rate. We then turned to size exclusion
chromatography (SEC) to determine if the complex formation can be
observed in a non-equilibrium system. In SEC, high ionic strength in the
buffer is essential for a good separation. In the following examples, 0.2
M NaCl was used except as otherwise indicated. The Ca2+-bound CaM
(Ca2+-CaM) was eluted as a sharp peak at 9.92 min while apo-CaM was
eluted at 9.81 min (Fig. 3A&D), the latter is consistent with a flexible
apo-CaM structure. The D-CMBD peptide was used because we can
simultaneously monitor its free and CaM-bound forms. D-CMBD was
eluted as a broad peak at 29.31 and 25.67 min in the presence of Ca2+
and EDTA, respectively (Fig. 3B&D). The CMBD peptide is unstructured
as seen in Circular Dichroism (data not shown) and appears to chelate
with the Ca2+ ions, which forms a more compact peptide. In the presence

3.2. Characterization of the interactions between CaM and Nox5’s
dehydrogenase domain
3.2.1. Expression of Nox5’s partial DH constructs
Since Nox5’s DH (residues 403–719) is extremely insoluble and un
stable, we attempted to increase its solubility by fusing with thioredoxin,
glutathione transferase (GST) or maltose binding protein (MBP). How
ever, they were expressed as an inclusion body, except for the shorter
MBP-fused DH constructs. Previously, we have expressed and purified
the partial Nox5’s DH constructs with MBP attached in their N-terminus,
which include the residues 665–719 and 605–719 (i.e., MBP-DH665-719
and MBP-DH605-719). MBP-DH605-719 contains REFBD and CMBD se
quences while MBP-DH665-719 contains only the CMBD sequence, which
allowed us to conclude that the REFBD sequence is the sole binding site
for Nox5’s EFD. Here we extended the DH constructs by including the
residues 584–719 and 528–719 to generate MBP-DH584-719 and MBPDH528-719 (Fig. 4), in which we aimed to assess their protein folding in
terms of binding to Nox5’s EFD and CaM. Further, the longer DH con
structs will allow us to extract information such as structural changes.
Interestingly, these two constructs were found in higher extent in the
soluble portion. All the DH constructs contain the CMBD and REFBD
binding sites except MBP-DH665-719 that only contains the CaM binding
site. For clarity, we omitted MBP in naming those DH constructs
throughout the text.
MBP-fused proteins are typically purified through an amylose col
umn. However, the protein purified by a single chromatography is not
sufficient for binding studies, especially for stoichiometry determina
tion. We found that an ion-exchange column (i.e., DEAE-cellulose) prior
to and/or CaM-immobilized column after the amylose column signifi
cantly increase the purity. An example of the purified DH528-719 is shown
in Fig. S3 and only those with sufficient purity were used for biophysical
characterization.
Despite of the high purity of the DH proteins as seen in SDS-PAGE,
the concentrated samples are only stable for days in the presence of
Ca2+ at 4oC. The degradation appears to be attributed from the trace
amount of the Ca2+-dependent protease(s) that were strongly associated
with the MBP-fused DH proteins. Including serine protease inhibitors,
such as phenylmethylsulfonyl fluoride (PMSF) or benzamidine, partially
suppressed the degradation.
3.2.2. The oligomeric states of DH by SEC and DLS
Since there is evidence that Nox5 formed a oligomer when it was
expressed in HEK293 cell line [22], we used SEC to monitor its oligo
meric states. When DH584-719 was injected into a gel filtration column
equilibrated with 50 mM Tris, pH 7.5, 0.2 M NaCl, we observed a major
peak at 6.7 min and a very minor peak near 9.5 min (Fig. 5B). Bovine
serum albumin (BSA) running on the same conditions shows three
distinct peaks at 8.57, 7.76, and 7.23 min, which are the BSA monomer
(66 kDa), dimer (132 kDa), and trimer (198 kDa), respectively. It ap
pears that the first peak containing the heterogenous DH macromole
cules with the predominate species having molecular weights larger
than BSA trimer. The anticipated MBP-fused DH584-719 monomer is 56
kDa, and it was eluted much later (9.5 min) than the BSA monomer
(8.57 min), suggesting that the MBP-fused DH protein has a more
compact structure than BSA. In fact, a similar observation was seen in

Fig. 3. Size Exclusion Studies of CaM and CMBD peptide binding. The HPLCSEC was performed in a buffer containing 50 mM Tris, 0.2 M NaCl, 2 mM
Ca2+ or 1 mM EDTA, pH 7.5. (A) and (B) show the elution profiles of CaM and
D-CMBD, respectively. (C) shows that D-CMBD was found to be complexed with
Ca2+-CaM when a large excess of CaM was included. The dotted line presents
that the fractions exhibited Dansyl fluorescence. (D) shows the mixture con
taining CaM and D-CMBD was separated in the absence of Ca2+. No Dansyl
fluorescence was found in the CaM fractions.
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Fig. 4. Sequence alignment of human Nox5 DH (hDH) and Cylindrospermum stagnale Nox5 DH (csDH). The arrow keys indicate the start points for the truncated
hDH proteins used in this study. The sequence in red is REFBD and the sequence in brown is CMBD. The putative Caveolin binding site of hDH is shown in blue color.
(For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

hemoglobin tetramer (~62 kDa), which was eluted out at 9.51 min in
our condition (data not shown). In other words, using BSA as standards
for SEC underestimates the molecular weight for compact proteins [23].
The presence of reducing agent DTT and Ca2+ ions did not affect its
HPLC profile, excluding the possibility of intermolecular disulfide for
mation and Ca2+-induced oligomer formation.
We then employed Dynamic Light Scattering (DLS) to study the DH,
which shows that the decay of the autocorrelation function was

substantially longer than 100 μs for DH584-719 (Fig. 5A). The fitting
revealed a highly multimeric macromolecule with the hydrodynamic
radius (Rh) = 8.3 nm with 42.5% of poly-distribution (%pd). The esti
mated average molecular weight was ~450 kDa with the assumption of
Raleigh sphere for molecules. However, we should point out that the
determined molecular weight should be viewed as qualitative because of
the limited application using dynamic scattering (instead of static scat
tering) for molecule wight determination. In comparison, CaM was
eluted out at 9.92 min in SEC and has a fast autocorrelation decay. Note
that CaM used contains a six-histidine tag and its anticipated molecular
weight is 18,132 Da. The fitting gave the Rh value of 2.0 nm (~18 kDa)
with the pd% value of 19.5. Since the DH protein is fused with MBP, it is
possible that the multimer is due to the self-oligomerization of MBP.
However, when the purified MBP was subjected to the SEC and DLS
measurements, it was eluted out at 9.55 min and has Rh = 2.6 nm with
the %pd of 10.1 at the same settings. Therefore, we concluded that the
oligomer formation is attributed to the DH protein, not the MBP.
To further study the possible oligomeric states, we included mild
chaotropic agent (2 M urea) to dissociate the DH584-719 oligomer
partially. We observed four distinct peaks at 6.71, 7.25, 8.02, and 9.52
min (Fig. 6A). We assigned the Species 1 and 2 at 9.52 and 8.02 min to be
DH monomer and dimer, respectively, while the Species 3 at 7.25 min
was assigned to be DH trimer (~168 kDa) and the Species 4 at 6.71 min
to be tetramer (~224 kDa). Note that these assignments are for the
presentation purpose as the resolution from our SEC and DLS cannot
determine the oligomeric states precisely. We found that all other DH
constructs have dominant trimer and tetramer species (or Species 3 and
4) with small amounts of monomer and dimer species. The equilibrium
between these two dominant species depends on the ionic strength. For
example, the tetramer species is dominated in a buffer with a lower ionic
strength (e.g., in the presence of 0.2 M NaCl); but the trimer species is a
major form in the high ionic strength buffer containing >0.25 M NaCl
(Fig. 6B). A significant tetramer formation was also found when DH
concentrations were higher. (Fig. 6B).
Next, we studied the interaction of CaM and DH using HPLC-SEC.
Since the DH584-719 and DH528-719 are significantly larger than the
other shorter constructs, they are separated from CaM better in SEC. We
only showed their results here despite of a similar trend for all con
structs. When 50 μM DH584-719 and 10–50 μM CaM were mixed in
presence of Ca2+, the elution profile revealed a new peak with the

Fig. 5. The oligomeric states of DH and CaM determined by DLS and SEC. (A)
The autocorrelation functions of 1 mg/mL CaM (Red) and DH584-719 (Blue) in
50 mM Tris, pH 7.5 were measured to determine their sizes and distribution
(Insert, Top: DH584-719, bottom: CaM). (B) The SEC elution profiles of CaM (18
kDa) and MBP-DH584-719 (56 kDa) were compared with BSA (dotted line) in the
presence of 50 mM Tris, pH 7.5, 0.2 M NaCl. (For interpretation of the refer
ences to color in this figure legend, the reader is referred to the Web version of
this article.)
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Fig. 6. Size Exclusion chromatography for the interaction of CaM and DH. (A) shows the DH584-719 in the absence (dotted line) and presence (solid line) of 2 M urea
in 50 mM Tris, pH 7.5, 0.2 M NaCl. The notations for M, D, Tri, and Tetra are for monomer, dimer, trimer, and tetramer, respectively. (B) shows the effects of ionic
strength and concentration on the DH oligomeric states. A 20 μL of the different concentrations of DH584-719 (43, 87, 175, 350, ad 700 μM) was subjected to SEC in a
higher ionic strength (>0.25 M NaCl), in which the condition favors trimer formation. (C) shows the 20 μL of the samples incubated overnight at 4oC containing 45
μM DH584-719 and 45 (solid), 90 (dashed line), 120 (dash-dotted line), or 180 μM CaM (dotted line) were injected into a HPLC-SEC in a buffer containing 0.2 M NaCl
and 2 mM Ca2+. The insert shows the SDS-PAGE from the samples containing CaM (Lane 1), DH584-719 (Lane 3) and the mixture of DH584-719 and CaM (1:2 ratio) after
30 min incubation at RT (Lane 2). (D) shows the samples containing 50 μM DH584-719 alone (dotted line) and plus 50 μM CaM (solid line) in a buffer containing 50
mM Tris, pH 7.5, 0.2 M NaCl, 2 mM Ca2+. (E) shows that same reaction condition as in (D) except that DH528-715 and D-CaM were used. Note that the multimers of the
larger DH528-719 (MW = ~62 kDa) were eluted earlier than DH584-719. The elution fractions were subjected to Dansyl fluorescence measurement (dotted line with
symbols). (F) shows an identical reaction condition as in (E) except that the buffer contains 1 mM EDTA.

elution time at 7.2 min, corresponding to a molecular weight compa
rable to that of trimer (Fig. 6D). Furthermore, the dimer disappeared as
judged by the disappearance of the shoulder near 8 min. To confirm the
change is due to CaM binding, we replaced CaM with D-CaM and per
formed a similar measurement. When the equal amounts of D-CaM and
DH528-719 were mixed and injected to HPLC (Fig. 6E), the eluted frac
tions were subjected to the Dansyl fluorescence measurements, where
approximately half of the D-CaM was found in the fractions containing
DH while the other half remains in the unbound form. The DH-bound DCaM was also evidenced by its maximal emission wavelength at 500 nm
while D-CaM alone showed the λmax value at 516 nm (Fig. 8A). While we
cannot obtain stoichiometry information in SEC, we anticipated that
including a large excess of CaM should shift the equilibrium solely to
ward the CaM/DH complex, if it is stable in a non-equilibrium system. It
was surprising to us that when including higher amount of CaM (e.g., >2
folds) or long incubation time (Fig. S4) resulted in a significant decrease
in the multimer and increase in the fractions corresponding to the DH
monomer (Fig. 6C), the latter was determined to be the products of
degradation (Insert in Fig. 6C). Though it is unclear the source and types
of contaminated proteases, Ca2+-CaM speeds up the degradation by
opening the DH structure to become accessible for proteases, in which
the rate of degradation depends on the amount of CaM present in so
lution (i.e., the ratio of DH and CaM). As expected, we did not observe
any Dansyl fluorescence in the DH fractions in the absence of Ca2+

(Fig. 6F).
3.2.3. Pulldown experiments revealed that both half-domains of CaM
interact with DH constructs
In the peptide-model study, CaM binding to CMBD peptide involves
its two half-domains. To determine whether this is the case for DH,
pulldown experiments were conducted. Fig. 7 shows that when DH665719 was loaded into a column immobilized with CFP-CaM followed by
elution with EDTA solution (for chelating Ca2+ ions). As expected, the
binding of CaM and DH665-719 was only observed in the presence of
Ca2+. When the immobilized CaM was replaced with N- and C-terminal
half domains of CaM (NCaM and CCaM), DH665-719 was retained in the
column in the presence of Ca2+, supporting that both half lobes of CaM
participate in the binding to DH. The similar reproducible results were
observed for all DH constructs.
3.2.4. Studies of CaM binding to DH constructs by fluorescence and ITC
To study the CaM-DH interaction by fluorescence, we prepared
Dansyl-labeled CaM (D-CaM) [21] and determined its binding to all
Nox5’s DH constructs by fluorescence spectroscopy. Fig. 8A is a repre
sentation of a solution of DH665-719 that was titrated into a solution
containing 2 μM D-CaM in the presence of Ca2+. The fluorescence in
creases and the maximal emission wavelength (λmax) is shifted from 510
to 480 nm, a significant difference to the D-CaM/CMBD system that
7
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lower panel). Including up to 0.25 M NaCl resulted in only a small
decrease in binding affinity. Contrast to the CaM/CMBD system, we did
not observe any Dansyl fluorescence intensity changes in the absence of
Ca2+. The binding measurements for other DH constructs are tabulated
in Table 2.
Additionally, we employed ITC to determine binding constants and
enthalpy changes. When a solution of CaM was titrated into 20–50 μM
DH605-719, the binding is exothermic and the affinity was determined to
be in the range of 106 M-1, but the stoichiometry (nCaM/DH) is signifi
cantly lower than 1 (Fig. S6A). The low stoichiometry was not expected.
Interestingly, there is a correlation between the obtained n values and
the concentrations of DHs used (Fig. S6B). In fact, the low stoichiometry
was due to the DH degradation during the process for sample prepara
tion and the ITC measurements (the total time was more than 4 h),
evidenced by a notable baseline drift in the uncorrected baseline in ITC
(Insert in Fig. S6A). It is possible that the higher amounts of DH used
contained more contaminated proteases, which renders DH more
degradable when CaM was titrated.
When the DH concentrations were near 2 μM range, the binding af
finity was determined to be ~5 x106 M-1 with a stoichiometry near one
and the ΔHCaM of − 8.2 kcal/mol (Fig. 8B&C and Table 2). The obtained
unity stoichiometry is consistent with that obtained from fluorescence,
indicating that the DH degradation was insignificant in this condition
(otherwise, we should see the stoichiometry is less than 1 because of less
DH available for CaM binding). Our results also revealed that DH665-719
has a lower heat enthalpy value, which is comparable to the peptidebased study, while the larger constructs have more negative enthalpy
changes, indicating a conformational change that renders more noncovalent interactions (Table 2).

Fig. 7. Pulldown experiment showing the interaction between Ca2+-CaM and
DH665-719. A solution containing 1.0 mg MBP-fused DH665-719 (Lane C; M.W. =
~49.2 kDa) was loaded into columns immobilized with fluorescent protein
fused CaM, NCaM, and CCaM in the presence of Ca2+ (Lane 2, 4, 6) and EDTA
(Lane 1, 3, 5). After washing, the proteins were eluted with EDTA and run on a
12% SDS-PAGE.

4. Discussion and conclusion

shows a very small intensity (Fig. S5). The result suggests that the
microenvironment of Dansyl group in CaM is more protected when
bound with DH than with CMBD. We fit the titration data and obtained
the Ka value of 4.90 × 106 M-1 with near unity stoichiometry (Fig. 8A

To better understand the binding mechanism for CaM and Nox5, we
revisited the system by studying the interactions between CaM and the

Fig. 8. CaM Binding to DH determined by fluorescence and ITC. (A) shows a representation of a solution of DH665-719 that was titrated into a solution containing 2
μM D-CaM in the presence of Ca2+. The initial and final scans show the blue shift in emission wavelength (Upper Panel). The lower panel shows the resulting fitting.
(B) shows the representation of the binding for the titration of 0.2 mM CaM to 2.5 μM DH665-719 in the presence of 50 mM Tris, pH 7.5, 2 mM Ca2+ at 25oC. (C) shows
the titration by adding 0.1 mM CaM to 2 μM DH528-719 in an identical condition. The average values of Ka and n are tabulated in Table 2.
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Table 2
The CaM binding to DHs by fluorescence and ITC in the presence of 50 mM Tris, pH 7.5, 2 mM Ca2+.
Binding by Fluorescence (titrant/analyte)

Binding constant (M-1)

DH665-719/D-CaM
DH605-719/D-CaM
DH584-719/D-CaM
DH528-719/D-CaM

(4.90
(2.52
(1.82
(1.39

Binding by ITC (titrant/analyte)

Binding constant (M-1)

CaM/DH665-719
CaM/DH605-719
CaM/DH584-719
CaM/DH528-719

(1.39
(8.94
(9.33
(2.71

± 0.28) ×
± 0.51) ×
± 0.43) ×
± 0.21) ×
± 0.26) ×
± 0.65) ×
± 0.15) ×
± 0.23) ×

Stoichiometry (n[Peptide]/[Protein])

6

10
106
106
106

0.92 ±
1.02 ±
0.89 ±
0.92 ±

6

10
105
105
106

Nox5’s CMBD peptide using intrinsic/extrinsic fluorescence and
isothermal titration calorimetry. The fluorescence characterization in
dicates that the Trp residue of CMBD becomes buried in a non-polar
environment and, therefore, protected from dynamic quenching upon
Ca2+-CaM binding. Without Ca2+, CaM binds the CMBD peptide via nonspecific electrostatic interaction which is not biologically significant.
The binding affinity for the CaM/CMBD was determined to be more
precisely in the range of 106 M-1 by extrinsic fluorescence and ITC, about
half to one-order lower than the previous reported value. However, CaM
binds two CMBD peptides using its half-domains with similar in
teractions (e.g., similar binding enthalpy); no cooperativity was
observed. Previously, we hypothesized that the extent of the hydro
phobic changes from the ANS fluorescence provides information on the
mode of CaM binding to its targeted peptides [11]. The “collapsed” form
of Ca2+- and CMBD-bound CaM would have a substantial ANS fluores
cence decrease while the “extended” form has less significant change.
ANS fluorescence of CaM/CMBD decreases ~3% and therefore, we hy
pothesized that Ca2+-CaM binds two Nox5’s CMBD peptides in an
extended structure [11], further supported by a small intensity change
for D-CaM/CMBD (Fig. S5).
The conclusion from our solution study here is consistent with a
recently published crystal structure [17], in which the peptide-bound
CaM has an identical structure to Ca2+-CaM (the “extended” struc
ture), and each of the two CMBD peptides is bound in the cleft formed in
half-domain. Interestingly, the crystal structure show that the CaM’s
N-terminal lobe binds to the C-terminal half of one CMBD peptide while
its C-terminal lobe binds to the N-terminal half of the other CMBD
peptide. Though one can argue that the determined stoichiometry from
the fitting largely depends on the accuracy of the concentrations used for

0.10
0.23
0.32
0.24

Stoichiometry (n[peptide]/Protein])

ΔHDH (kcal/mol)

1.15 ±
1.15 ±
1.04 ±
1.18 ±

−
−
−
−

0.07
0.02
0.16
0.05

8.21 ± 1.62
14.80 ± 1.71
16.75 ± 2.23
18.96 ± 1.25

fitting, here we have used different characterizations but yielded
consistent results. A more concrete approach to confirm this is to
generate, for instance, an MBP-fused CMBD protein (MBP-CMBD) and to
determine whether a larger complex containing one CaM and two
MBP-CMBD can be seen in SEC. Unfortunately, such a protein construct
was not expressed in our system.
Next, we studied the interaction using the truncated DH constructs.
Though Nox5’s DH is not soluble in bacterial expression system, four
soluble MBP-fused DH truncated forms were obtained in a large quantity
with DH528-719 found most soluble, which may be due to that it forms a
stable subdomain as shown in the modeled structure based on the DH of
Cylindrospermum stagnale Nox5 (csNox5’s DH) (Fig. 9A). All DH con
structs appear to be folded correctly. Their CMBD sequence is accessible
to CaM, and the binding affinity is comparable to the study from the
CaM/CMBD system except the stoichiometry, in which we found a ratio
of 1:1 for CaM:DH. The study using DH for CaM binding is not trivial
since the csDH has the CMBD region (Fig. 4) formed as a helical struc
ture. Because of the conformation, several key residues of CMBD inter
acting with CaM are buried and, therefore, no CaM binding was
observed which is reasonable to conclude that CaM does not play a role
for csNox5 because of lacking CaM in bacteria. Because csDH has been
found as monomer in crystallography [24], we hypothesized that the
CMBD sequence partially buried in hDH monomer becomes exposed
upon oligomerization. The unity stoichiometry determined by using
micromolar DH suggests that the binding mode of CaM to Nox5 is
different to the peptide-based system. It is likely that CaM binds to the
CMBD region of DH in a “collapsed” model as seen in the complex
formed by CaM and CMBD of eNOS [11]. An indication is from the
significant Dansyl fluorescent change for D-CaM/DH compared with

ences to color in this figure legend, the reader is referred to the Web version of this article.)
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Fig. 9. The human NOX5’s DH modeled structure
and the oligomeric States of Nox5’s DH. (A) shows
the Nox5’s DH structure modeled as previously
except the CMBD sequence (Orange) was shown as a
random coil. Adjacent to CMBD are REFBD site (Blue)
for Nox5’s EFD binding and Cav-B site (Yellow) for
caveolin binding. Note that the structure of Cav-B
appears to be artifactual since there are eight addi
tional residues PWLELAAA (not shown in the model)
were added immediately after the C-terminal end of
csDH for FAD binding [24]. In hDH, these three ele
ments are structurally close and binding to one likely
affects the binding to the others. The arrow indicates
the 1st residue in DH528-719 that was found most
soluble. (B) shows the equilibrium between oligo
meric states for hDH. The assignments are based on
the MBP-fused DH584-719 (56 kDa). The predominated
species for the expressed DH are trimer and tetramer,
in which the equilibrium is affected by concentration
and ionic strength. The 1:1 stoichiometry for CaM
(18 kDa) binding to DH was determined by ITC and
fluorescence, and the binding stabilized the dimeric
DH as seen in SEC. (For interpretation of the refer
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that of D-CaM/CMBD.
Our data is also consistent with the previous report, in which Nox5
expressed in HEK293 cells is an oligomer, possibly tetramer. The authors
suggest that Nox5 form an oligomer through its DH domain, and such
multimerization is required for the Nox5’s s activity [22]. Based on our
data, we proposed the role of CaM in the DH oligomeric states as shown
in Fig. 9B. The Nox5’s DH are expressed as oligomers, which is
Ca2+-independent. Human Nox5’s DH is possibly in the forms of trimer
and tetramer, in which its equilibrium is concentration and ionic
strength dependent. CaM binding appears to stabilize the DH dimeric
form. How the oligomeric states of Nox5 related to its superoxide
generating activity are largely unclear. Since the shortest truncated DH
protein, DH665-719, was also expressed as oligomers, it suggests that the
region after the CMBD sequence is crucial for oligomer formation.
It is interesting that the C-terminal end of hNox5 contains a binding
site for caveolin-1 (Cav-1) (Figs. 4 & 9A), which is responsible for its
localization in the caveola structure. The Cav-1 binding sequence (CavB) shares a conserved sequence- ΦXΦXXXXΦ or ΦXXXXΦXXΦ (Φ is an
aromatic amino acid and X is any residue). The peptide from the scaffold
domain of Cav-1 (Cav-1P) has been shown to inhibit the Nox5’s
superoxide-generating activity [13]. Because the C-terminal end of
csNox5 does not contain Cav-B sequence (Fig. 4) and is found to be a
monomer in crystal structure, we suspect that this nonpolar c-terminal
end may also play a role in oligomer formation. A closely related
hemoflavoprotein protein, nitric oxide synthase (Nos), contains the
CMBD (residues 492–511 in endothelial NOS (eNOS)) and Cav-B (resi
dues 350–358 in bovine eNOS) sequences [25]. It has been shown that a
Cav-1p (residues 82–101) inhibits the NO production [26]. The NO ac
tivity is completely restored by CaM binding [27,28]. Therefore, the role
of CaM in Nox5, in addition to increasing Ca2+-sensitivity, may be
crucial for lifting inhibitory effect by Cav-1. How the interplay among
Nox5, CaM, and Cav-1 in related to Nox5’s oligomeric state is largely
unknown.
Fig. 9A shows the modeled hDH based on the structure of csDH using
homolog modeling [11], except its CMBD sequence was modeled as a
random coil to allow the interaction with CaM. In this model, the se
quences of REFBD (recognized by Nox5’s EFD), CMBD (bound by CaM)
and Cav-B (for Cav-1 binding) are close each other in the primary
sequence and three-dimensional structure, suggesting the binding to one
of each element possibly affects the others. Interestingly, our result
seems to support this hypothesis, at least for the conformational changes
between REFBD and CMBD. For example, the heat enthalpy changes for
CMBD-and-REFBD containing DH constructs (i.e., DH605-719, DH584-719,
and DH528-719) is approximately double than that of CMBD-containing
DH665-719, indicating an induced conformational change occurred.
Furthermore, a conformational change included by Ca2+-CaM binding
has rendered the DH proteins more accessible for protease degradation.
The interplay among those components with their associated proteins
appears to be crucial to activate and regulate the Nox5
superoxide-generating activity. How these bindings are relevant to
oligomeric states are equally unclear. However, our result provides in
sights for Nox5’s DH oligomeric states and its related structural changes
that are crucial to understand the No5’s activation and regulation
mechanism.
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